Neutralizing antibody against anti–SARS-CoV-2 vaccination
Investigating the impact of treatment with anti-CD20 MoAb on the production of neutralizing antibody against anti–SARS-CoV-2 vaccination. Read more.
Kyoto Clinical Hematology Study Group Association Between Time Cov Nab Between Time Factors Associated Multivariate Analyses
Source: dovepress.com